First Citizens Bank & Trust’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.9M Buy
43,514
+1,187
+3% +$255K 0.16% 87
2026
Q1
$9.21M Buy
42,327
+8,362
+25% +$1.85M 0.19% 88
2025
Q4
$7.76M Sell
33,965
-869
-2% -$198K 0.16% 94
2025
Q3
$8.07M Sell
34,834
-2,433
-7% -$495K 0.17% 95
2025
Q2
$6.92M Sell
37,267
-3,614
-9% -$672K 0.13% 98
2025
Q1
$8.57M Sell
40,881
-6
-0% -$1.17K 0.22% 73
2024
Q4
$7.27M Sell
40,887
-1,529
-4% -$281K 0.13% 83
2024
Q3
$8.38M Sell
42,416
-624
-1% -$116K 0.18% 81
2024
Q2
$7.38M Buy
43,040
+1,038
+2% +$172K 0.14% 86
2024
Q1
$7.65M Buy
42,002
+36,100
+612% +$6.22M 0.15% 80
2023
Q4
$915K Buy
5,902
+108
+2% +$15.7K 0.02% 210
2023
Q3
$864K Sell
5,794
-508
-8% -$74.6K 0.02% 204
2023
Q2
$849K Buy
6,302
+50
+0.8% +$7.33K 0.02% 210
2023
Q1
$996K Sell
6,252
-11,728
-65% -$1.79M 0.02% 183
2022
Q4
$2.91M Sell
17,980
-8,685
-33% -$1.33M 0.09% 98
2022
Q3
$3.58M Buy
26,665
+6,070
+29% +$871K 0.12% 84
2022
Q2
$3.15M Sell
20,595
-4,158
-17% -$635K 0.11% 94
2022
Q1
$4.01M Buy
24,753
+1,357
+6% +$197K 0.16% 89
2021
Q4
$3.17M Buy
23,396
+6,365
+37% +$752K 0.12% 99
2021
Q3
$1.84M Sell
17,031
-698
-4% -$79.8K 0.09% 124
2021
Q2
$2M Sell
17,729
-54
-0.3% -$6.08K 0.09% 119
2021
Q1
$1.92M Sell
17,783
-20,042
-53% -$2.14M 0.09% 135
2020
Q4
$4.05M Sell
37,825
-4,623
-11% -$444K 0.21% 76
2020
Q3
$3.72M Buy
42,448
+4,538
+12% +$427K 0.26% 73
2020
Q2
$3.72M Buy
37,910
+24,870
+191% +$2.19M 0.31% 77
2020
Q1
$993K Buy
13,040
+744
+6% +$63.4K 0.12% 156
2019
Q4
$1.09M Sell
12,296
-1,008
-8% -$83.7K 0.1% 167
2019
Q3
$1.01M Buy
13,304
+1,106
+9% +$75.8K 0.12% 180
2019
Q2
$887K Buy
12,198
+862
+8% +$67.8K 0.1% 201
2019
Q1
$914K Sell
11,336
-1,742
-13% -$143K 0.1% 190
2018
Q4
$1.21M Sell
13,078
-311
-2% -$27.3K 0.15% 155
2018
Q3
$1.27M Sell
13,389
-18,061
-57% -$1.71M 0.14% 175
2018
Q2
$2.91M Buy
31,450
+4,842
+18% +$473K 0.36% 75
2018
Q1
$2.52M Buy
26,608
+10,675
+67% +$1.17M 0.34% 83
2017
Q4
$1.54M Sell
15,933
-2,005
-11% -$189K 0.21% 129
2017
Q3
$1.59M Sell
17,938
-9,780
-35% -$744K 0.21% 129
2017
Q2
$2.01M Sell
27,718
-2,623
-9% -$176K 0.26% 117
2017
Q1
$1.98M Sell
30,341
-54,523
-64% -$3.43M 0.24% 119
2016
Q4
$5.31M Sell
84,864
-31,504
-27% -$1.92M 0.58% 51
2016
Q3
$7.34M Sell
116,368
-10,401
-8% -$673K 0.67% 50
2016
Q2
$7.85M Sell
126,769
-7,658
-6% -$467K 0.7% 45
2016
Q1
$7.68M Sell
134,427
-11,248
-8% -$627K 0.64% 52
2015
Q4
$8.63M Sell
145,675
-13,416
-8% -$773K 0.63% 50
2015
Q3
$8.66M Buy
159,091
+87,536
+122% +$5.7M 0.64% 52
2015
Q2
$4.81M Buy
71,555
+14,861
+26% +$970K 0.33% 90
2015
Q1
$3.32M Buy
+56,694
New +$3.43M 0.23% 107
2014
Q4
Sell
-16,964
Closed -$980K 326
2014
Q3
$980K Buy
+16,964
New +$942K 0.08% 152
2013
Q4
Sell
-149,903
Closed -$6.71M 327
2013
Q3
$6.71M Buy
149,903
+3,462
+2% +$153K 0.26% 106
2013
Q2
$6.05M Buy
+146,441
New +$6.4M 0.25% 109

Other funds holding ABBV

First Citizens Bank & Trust's ABBV Position: Q2 2026 in Review

First Citizens Bank & Trust increased its AbbVie (ABBV) stake by 2.8% in Q2 2026, buying an estimated $255K and bringing the position to 43,514 shares worth $10.9M. The position accounts for 0.16% of the portfolio, ranked #87.

First Citizens Bank & Trust first reported a position in ABBV in Q2 2013 and has held it in 49 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • First Citizens Bank & Trust held 43,514 shares of AbbVie worth $10.9M as of Q2 2026.
  • First Citizens Bank & Trust bought 1,187 AbbVie shares in Q2 2026, an estimated $255K.
  • AbbVie made up 0.16% of First Citizens Bank & Trust's portfolio in Q2 2026, its #87 holding.
  • First Citizens Bank & Trust first reported a position in AbbVie in Q2 2013 and has held it in 49 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on First Citizens Bank & Trust's 13F filing for Q2 2026, filed 13 Jul 2026.